On the recordMarch 27, 2023
It is all about money.
Source
congress.govIt is all about money.
Eshoo asserts that financial gain drives PBMs' pricing strategies.
Share & report
More from Anna Eshoo
The Republican majority's actions are inconsistent with their calls for bipartisan collaboration.
The next reauthorization must not repeat the failures of the 2018 law and should address its deficiencies.
The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.
This is, as you said and have said many times, this is a devastating disease, and I don't think this can be treated as 17 months of a little additional hope.